Review



polyclonal anti bai1 antibody  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Novus Biologicals polyclonal anti bai1 antibody
    Figure 1 | Stabilin-2 expression in muscle tissues and during myogenic differentiation. (a) The expressions of PS-recognizing receptors (Tim1, Tim4, <t>Bai1,</t> stabilin-1 and stabilin-2) were examined in mouse skeletal muscles by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. (b,c) Expression levels of PS-recognizing receptors were examined in C2C12 cells (b) and primary myoblasts (c) during myogenic differentiation by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. GM, growth medium; DM, differentiation medium. (d,e) Expression levels of stabilin-2 protein were determined in C2C12 cells (d) and primary myoblasts (e) during myogenic differentiation by Western blotting. Representative results from three independent experiments are shown. MyHC, myosin heavy chain. Full-size blots are shown in Supplementary Fig. 15. (f,g) C2C12 cells (f) and primary myoblasts (g) were induced to differentiate in differentiation medium (DM), and the expressions of stabilin-2 and myosin heavy chain (MyHC) were analysed at the indicated times by immunostaining. Scale bar, 50 mm.
    Polyclonal Anti Bai1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal anti bai1 antibody/product/Novus Biologicals
    Average 90 stars, based on 10 article reviews
    polyclonal anti bai1 antibody - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration."

    Article Title: Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration.

    Journal: Nature communications

    doi: 10.1038/ncomms10871

    Figure 1 | Stabilin-2 expression in muscle tissues and during myogenic differentiation. (a) The expressions of PS-recognizing receptors (Tim1, Tim4, Bai1, stabilin-1 and stabilin-2) were examined in mouse skeletal muscles by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. (b,c) Expression levels of PS-recognizing receptors were examined in C2C12 cells (b) and primary myoblasts (c) during myogenic differentiation by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. GM, growth medium; DM, differentiation medium. (d,e) Expression levels of stabilin-2 protein were determined in C2C12 cells (d) and primary myoblasts (e) during myogenic differentiation by Western blotting. Representative results from three independent experiments are shown. MyHC, myosin heavy chain. Full-size blots are shown in Supplementary Fig. 15. (f,g) C2C12 cells (f) and primary myoblasts (g) were induced to differentiate in differentiation medium (DM), and the expressions of stabilin-2 and myosin heavy chain (MyHC) were analysed at the indicated times by immunostaining. Scale bar, 50 mm.
    Figure Legend Snippet: Figure 1 | Stabilin-2 expression in muscle tissues and during myogenic differentiation. (a) The expressions of PS-recognizing receptors (Tim1, Tim4, Bai1, stabilin-1 and stabilin-2) were examined in mouse skeletal muscles by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. (b,c) Expression levels of PS-recognizing receptors were examined in C2C12 cells (b) and primary myoblasts (c) during myogenic differentiation by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. GM, growth medium; DM, differentiation medium. (d,e) Expression levels of stabilin-2 protein were determined in C2C12 cells (d) and primary myoblasts (e) during myogenic differentiation by Western blotting. Representative results from three independent experiments are shown. MyHC, myosin heavy chain. Full-size blots are shown in Supplementary Fig. 15. (f,g) C2C12 cells (f) and primary myoblasts (g) were induced to differentiate in differentiation medium (DM), and the expressions of stabilin-2 and myosin heavy chain (MyHC) were analysed at the indicated times by immunostaining. Scale bar, 50 mm.

    Techniques Used: Expressing, Muscles, Real-time Polymerase Chain Reaction, Western Blot, Immunostaining



    Similar Products

    bai1 antibody  (Bio-Techne corporation)
    90
    Bio-Techne corporation bai1 antibody
    Bai1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bai1 antibody/product/Bio-Techne corporation
    Average 90 stars, based on 1 article reviews
    bai1 antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    polyclonal anti bai1 antibody  (Novus Biologicals)
    90
    Novus Biologicals polyclonal anti bai1 antibody
    Figure 1 | Stabilin-2 expression in muscle tissues and during myogenic differentiation. (a) The expressions of PS-recognizing receptors (Tim1, Tim4, <t>Bai1,</t> stabilin-1 and stabilin-2) were examined in mouse skeletal muscles by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. (b,c) Expression levels of PS-recognizing receptors were examined in C2C12 cells (b) and primary myoblasts (c) during myogenic differentiation by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. GM, growth medium; DM, differentiation medium. (d,e) Expression levels of stabilin-2 protein were determined in C2C12 cells (d) and primary myoblasts (e) during myogenic differentiation by Western blotting. Representative results from three independent experiments are shown. MyHC, myosin heavy chain. Full-size blots are shown in Supplementary Fig. 15. (f,g) C2C12 cells (f) and primary myoblasts (g) were induced to differentiate in differentiation medium (DM), and the expressions of stabilin-2 and myosin heavy chain (MyHC) were analysed at the indicated times by immunostaining. Scale bar, 50 mm.
    Polyclonal Anti Bai1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal anti bai1 antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    polyclonal anti bai1 antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    antibody anti-bai1 (n-terminal) (rabbit polyclonal) (h-270)  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology antibody anti-bai1 (n-terminal) (rabbit polyclonal) (h-270)

    Antibody Anti Bai1 (N Terminal) (Rabbit Polyclonal) (H 270), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody anti-bai1 (n-terminal) (rabbit polyclonal) (h-270)/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    antibody anti-bai1 (n-terminal) (rabbit polyclonal) (h-270) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    anti-bai1 rabbit polyclonal  (Covance)
    90
    Covance anti-bai1 rabbit polyclonal

    Anti Bai1 Rabbit Polyclonal, supplied by Covance, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-bai1 rabbit polyclonal/product/Covance
    Average 90 stars, based on 1 article reviews
    anti-bai1 rabbit polyclonal - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    rabbit anti-bai1 polyclonal antibody  (MyBiosource Biotechnology)
    90
    MyBiosource Biotechnology rabbit anti-bai1 polyclonal antibody
    Expression levels of BIRC5, VEGF, <t>BAI1</t> and MBD2 in different cell lines with or without BIRC5 siRNA. (A) Representative western blot analysis results and (B) relative protein expression level of BIRC5. (C) Representative western blot analysis results and (D) relative protein expression level of VEGF. (E) Representative western blot analysis results and (F) relative protein expression level of BAI1. (G) Representative western blot analysis results and (H) relative protein expression level of MBD2. *P<0.05 vs. untransfected cells. BIRC5, baculoviral IAP repeat containing 5; VEGF, vascular endothelial growth factor; BAI1, brain-specific angiogenesis inhibitor 1; MBD2, methyl-CpG binding domain protein 2; siRNA, small-interfering RNA.
    Rabbit Anti Bai1 Polyclonal Antibody, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-bai1 polyclonal antibody/product/MyBiosource Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit anti-bai1 polyclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    rabbit anti-bai1 affinity purified polyclonal antibody  (Millipore)
    90
    Millipore rabbit anti-bai1 affinity purified polyclonal antibody
    Expression of <t>BAI1</t> in normal brain tissue and astrocytoma specimens of various grades. The expression of BAI1 was higher in (A) normal brain tissues than (B) low-grade astrocytomas and (C) high-grade astrocytomas. BAI1 expression was higher in (B) low-grade astrocytomas than (C) high-grade astrocytomas. Scale bar = 30 μ m. (D) The LI of BAI1 decreased with the pathological grade of the astrocytoma (Spearman’s rank correlation, r=−0.519, P<0.01). * P<0.05 vs. grade I, II, III and IV astrocytomas, ** P<0.05 vs. grades III and IV, *** P<0.05 vs. grade IV. BAI1, brain-specific angiogenesis inhibitor 1; LI, labeling index; N, normal brain tissue.
    Rabbit Anti Bai1 Affinity Purified Polyclonal Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-bai1 affinity purified polyclonal antibody/product/Millipore
    Average 90 stars, based on 1 article reviews
    rabbit anti-bai1 affinity purified polyclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1 | Stabilin-2 expression in muscle tissues and during myogenic differentiation. (a) The expressions of PS-recognizing receptors (Tim1, Tim4, Bai1, stabilin-1 and stabilin-2) were examined in mouse skeletal muscles by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. (b,c) Expression levels of PS-recognizing receptors were examined in C2C12 cells (b) and primary myoblasts (c) during myogenic differentiation by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. GM, growth medium; DM, differentiation medium. (d,e) Expression levels of stabilin-2 protein were determined in C2C12 cells (d) and primary myoblasts (e) during myogenic differentiation by Western blotting. Representative results from three independent experiments are shown. MyHC, myosin heavy chain. Full-size blots are shown in Supplementary Fig. 15. (f,g) C2C12 cells (f) and primary myoblasts (g) were induced to differentiate in differentiation medium (DM), and the expressions of stabilin-2 and myosin heavy chain (MyHC) were analysed at the indicated times by immunostaining. Scale bar, 50 mm.

    Journal: Nature communications

    Article Title: Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration.

    doi: 10.1038/ncomms10871

    Figure Lengend Snippet: Figure 1 | Stabilin-2 expression in muscle tissues and during myogenic differentiation. (a) The expressions of PS-recognizing receptors (Tim1, Tim4, Bai1, stabilin-1 and stabilin-2) were examined in mouse skeletal muscles by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. (b,c) Expression levels of PS-recognizing receptors were examined in C2C12 cells (b) and primary myoblasts (c) during myogenic differentiation by quantitative real-time PCR. Data are presented as mean±s.d. of at least three independent experiments. GM, growth medium; DM, differentiation medium. (d,e) Expression levels of stabilin-2 protein were determined in C2C12 cells (d) and primary myoblasts (e) during myogenic differentiation by Western blotting. Representative results from three independent experiments are shown. MyHC, myosin heavy chain. Full-size blots are shown in Supplementary Fig. 15. (f,g) C2C12 cells (f) and primary myoblasts (g) were induced to differentiate in differentiation medium (DM), and the expressions of stabilin-2 and myosin heavy chain (MyHC) were analysed at the indicated times by immunostaining. Scale bar, 50 mm.

    Article Snippet: Polyclonal anti-Bai1 antibody (NBP1–00723) was obtained from Novus Biologicals.

    Techniques: Expressing, Muscles, Real-time Polymerase Chain Reaction, Western Blot, Immunostaining

    Journal: eLife

    Article Title: The adhesion-GPCR BAI1 shapes dendritic arbors via Bcr-mediated RhoA activation causing late growth arrest

    doi: 10.7554/eLife.47566

    Figure Lengend Snippet:

    Article Snippet: Antibody , anti-BAI1 (N-terminal) (rabbit polyclonal) (H-270) , Santa Cruz Biotechnology , Santa Cruz:sc-66815; RRID: AB_2062912 , (1:500).

    Techniques: Recombinant, Sequencing, Software

    Expression levels of BIRC5, VEGF, BAI1 and MBD2 in different cell lines with or without BIRC5 siRNA. (A) Representative western blot analysis results and (B) relative protein expression level of BIRC5. (C) Representative western blot analysis results and (D) relative protein expression level of VEGF. (E) Representative western blot analysis results and (F) relative protein expression level of BAI1. (G) Representative western blot analysis results and (H) relative protein expression level of MBD2. *P<0.05 vs. untransfected cells. BIRC5, baculoviral IAP repeat containing 5; VEGF, vascular endothelial growth factor; BAI1, brain-specific angiogenesis inhibitor 1; MBD2, methyl-CpG binding domain protein 2; siRNA, small-interfering RNA.

    Journal: Oncology Letters

    Article Title: Downregulation of BIRC5 inhibits the migration and invasion of esophageal cancer cells by interacting with the PI3K/Akt signaling pathway

    doi: 10.3892/ol.2018.8986

    Figure Lengend Snippet: Expression levels of BIRC5, VEGF, BAI1 and MBD2 in different cell lines with or without BIRC5 siRNA. (A) Representative western blot analysis results and (B) relative protein expression level of BIRC5. (C) Representative western blot analysis results and (D) relative protein expression level of VEGF. (E) Representative western blot analysis results and (F) relative protein expression level of BAI1. (G) Representative western blot analysis results and (H) relative protein expression level of MBD2. *P<0.05 vs. untransfected cells. BIRC5, baculoviral IAP repeat containing 5; VEGF, vascular endothelial growth factor; BAI1, brain-specific angiogenesis inhibitor 1; MBD2, methyl-CpG binding domain protein 2; siRNA, small-interfering RNA.

    Article Snippet: The membranes were then incubated with corresponding primary antibodies including rabbit anti-BIRC5 polyclonal antibody (dilution, 1:1,000; catalog no. MBS151070; MyBioSource, Inc., San Diego, CA, USA), rabbit anti-VEGF polyclonal antibody (dilution, 1:1,000; catalog no. bs-0279R; Biomathematics and Statistics Scotland, Edinburgh, Scotland), rabbit anti-BAI1 polyclonal antibody (dilution, 1:1,000; catalog no. MBS8242484; MyBioSource, Inc.), rabbit anti-MBD2 polyclonal antibody (dilution, 1:1,000; catalog no. MBS126361; MyBioSource, Inc.), rabbit anti-phospho (p)-Akt polyclonal antibody (dilution, 1:1,000; catalog no. MBS330024; MyBioSource, Inc.) and rabbit anti-GAPDH polyclonal antibody (dilution, 1:1,000; catalog no. MBS9216842; MyBioSource, Inc.) overnight at 4°C.

    Techniques: Expressing, Western Blot, Binding Assay, Small Interfering RNA

    Relative expression levels of BIRC5 mRNA and protein in different cell lines with or without SC79 treatment. (A) The effect of SC79 treatment on the expression levels of p-AKT in different cell lines. (B) Relative mRNA expression levels of BIRC5 in different cell lines. (C) Representative western blot analysis results of BIRC5. (D) Relative protein expression levels of BIRC5 in different cell lines. (E) The effect of SC79 treatment on the expression levels of VEGF in different cell lines. (F) The effect of SC79 treatment on the expression levels of BAI1 in different cell lines. (G) The effect of BAI1 treatment on the expression levels of MBD2 in different cell lines. *P<0.05 vs. untreated cells. BIRC5, baculoviral IAP repeat containing 5; VEGF, vascular endothelial growth factor; MBD2, methyl-CpG binding domain protein 2; BIRC5, baculoviral IAP repeat containing 5; VEGF, vascular endothelial growth factor; BAI1, brain-specific angiogenesis inhibitor 1; MBD2, methyl-CpG binding domain protein 2; p-Akt, phospho-Akt.

    Journal: Oncology Letters

    Article Title: Downregulation of BIRC5 inhibits the migration and invasion of esophageal cancer cells by interacting with the PI3K/Akt signaling pathway

    doi: 10.3892/ol.2018.8986

    Figure Lengend Snippet: Relative expression levels of BIRC5 mRNA and protein in different cell lines with or without SC79 treatment. (A) The effect of SC79 treatment on the expression levels of p-AKT in different cell lines. (B) Relative mRNA expression levels of BIRC5 in different cell lines. (C) Representative western blot analysis results of BIRC5. (D) Relative protein expression levels of BIRC5 in different cell lines. (E) The effect of SC79 treatment on the expression levels of VEGF in different cell lines. (F) The effect of SC79 treatment on the expression levels of BAI1 in different cell lines. (G) The effect of BAI1 treatment on the expression levels of MBD2 in different cell lines. *P<0.05 vs. untreated cells. BIRC5, baculoviral IAP repeat containing 5; VEGF, vascular endothelial growth factor; MBD2, methyl-CpG binding domain protein 2; BIRC5, baculoviral IAP repeat containing 5; VEGF, vascular endothelial growth factor; BAI1, brain-specific angiogenesis inhibitor 1; MBD2, methyl-CpG binding domain protein 2; p-Akt, phospho-Akt.

    Article Snippet: The membranes were then incubated with corresponding primary antibodies including rabbit anti-BIRC5 polyclonal antibody (dilution, 1:1,000; catalog no. MBS151070; MyBioSource, Inc., San Diego, CA, USA), rabbit anti-VEGF polyclonal antibody (dilution, 1:1,000; catalog no. bs-0279R; Biomathematics and Statistics Scotland, Edinburgh, Scotland), rabbit anti-BAI1 polyclonal antibody (dilution, 1:1,000; catalog no. MBS8242484; MyBioSource, Inc.), rabbit anti-MBD2 polyclonal antibody (dilution, 1:1,000; catalog no. MBS126361; MyBioSource, Inc.), rabbit anti-phospho (p)-Akt polyclonal antibody (dilution, 1:1,000; catalog no. MBS330024; MyBioSource, Inc.) and rabbit anti-GAPDH polyclonal antibody (dilution, 1:1,000; catalog no. MBS9216842; MyBioSource, Inc.) overnight at 4°C.

    Techniques: Expressing, Western Blot, Binding Assay

    Expression of BAI1 in normal brain tissue and astrocytoma specimens of various grades. The expression of BAI1 was higher in (A) normal brain tissues than (B) low-grade astrocytomas and (C) high-grade astrocytomas. BAI1 expression was higher in (B) low-grade astrocytomas than (C) high-grade astrocytomas. Scale bar = 30 μ m. (D) The LI of BAI1 decreased with the pathological grade of the astrocytoma (Spearman’s rank correlation, r=−0.519, P<0.01). * P<0.05 vs. grade I, II, III and IV astrocytomas, ** P<0.05 vs. grades III and IV, *** P<0.05 vs. grade IV. BAI1, brain-specific angiogenesis inhibitor 1; LI, labeling index; N, normal brain tissue.

    Journal: Oncology Letters

    Article Title: Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas

    doi: 10.3892/ol.2013.1250

    Figure Lengend Snippet: Expression of BAI1 in normal brain tissue and astrocytoma specimens of various grades. The expression of BAI1 was higher in (A) normal brain tissues than (B) low-grade astrocytomas and (C) high-grade astrocytomas. BAI1 expression was higher in (B) low-grade astrocytomas than (C) high-grade astrocytomas. Scale bar = 30 μ m. (D) The LI of BAI1 decreased with the pathological grade of the astrocytoma (Spearman’s rank correlation, r=−0.519, P<0.01). * P<0.05 vs. grade I, II, III and IV astrocytomas, ** P<0.05 vs. grades III and IV, *** P<0.05 vs. grade IV. BAI1, brain-specific angiogenesis inhibitor 1; LI, labeling index; N, normal brain tissue.

    Article Snippet: The sections were incubated with the following primary antibodies: rabbit anti-BAI1 affinity purified polyclonal antibody (AB9364, 1:1,000; Chemicon International, Temecula, CA, USA); CD105 (Endoglin) mouse monoclonal antibody (NCL-CD105, 1:100; Novocastra, Newcastle upon Tyne, UK); VEGF (C-1) mouse monoclonal antibody (sc-7269, 1:600; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); bFGF (147) rabbit polyclonal antibody (sc-79, 1:800; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).

    Techniques: Expressing, Labeling

    MVD in normal brain tissue and various grades of astrocytomas. MVD was lower in (A) normal brain tissues compared with (B) low-grade and (C) high-grade astrocytomas and higher in (C) high-grade astrocytomas than (B) low-grade astrocytomas. Scale bar = 30 μ m. (D) Astrocytoma specimens were divided into four groups according to their MVD value: group A, MVD ≤10; group B, 10< MVD ≤20; group C, 20< MVD ≤30; group D, MVD >30. * P<0.05 vs. group D. (E) The MVD value of the astrocytomas decreased with increasing BAI1 expression (Spearman’s rank correlation, r=−0.222, P<0.05). MVD, microvessel density; BAI1, brain-specific angiogenesis inhibitor 1.

    Journal: Oncology Letters

    Article Title: Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas

    doi: 10.3892/ol.2013.1250

    Figure Lengend Snippet: MVD in normal brain tissue and various grades of astrocytomas. MVD was lower in (A) normal brain tissues compared with (B) low-grade and (C) high-grade astrocytomas and higher in (C) high-grade astrocytomas than (B) low-grade astrocytomas. Scale bar = 30 μ m. (D) Astrocytoma specimens were divided into four groups according to their MVD value: group A, MVD ≤10; group B, 10< MVD ≤20; group C, 20< MVD ≤30; group D, MVD >30. * P<0.05 vs. group D. (E) The MVD value of the astrocytomas decreased with increasing BAI1 expression (Spearman’s rank correlation, r=−0.222, P<0.05). MVD, microvessel density; BAI1, brain-specific angiogenesis inhibitor 1.

    Article Snippet: The sections were incubated with the following primary antibodies: rabbit anti-BAI1 affinity purified polyclonal antibody (AB9364, 1:1,000; Chemicon International, Temecula, CA, USA); CD105 (Endoglin) mouse monoclonal antibody (NCL-CD105, 1:100; Novocastra, Newcastle upon Tyne, UK); VEGF (C-1) mouse monoclonal antibody (sc-7269, 1:600; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); bFGF (147) rabbit polyclonal antibody (sc-79, 1:800; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).

    Techniques: Expressing

    Expression of VEGF was lower in (A) normal brain tissues than in (B) low-grade and (C) high-grade astrocytomas and higher in (C) high-grade astrocytomas than (B) low-grade astrocytomas. Expression of bFGF was lower in (D) normal brain tissues than in (E) low-grade and (F) high-grade astrocytomas and higher in (F) high-grade astrocytomas than (E) low-grade astrocytomas. (G) VEGF expression in astrocytomas decreased with increased BAI1 expression (Spearman’s rank correlation, r=−0.379, P<0.01). (H) bFGF expression in astrocytomas decreased with increased BAI1 expression (Spearman’s rank correlation, r=−0.277, P<0.01). BAI1, brain-specific angiogenesis inhibitor 1; VEGF, vascular endothelial growth factor; bFGF, basic fibroblast growth factor; LI, labeling index.

    Journal: Oncology Letters

    Article Title: Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas

    doi: 10.3892/ol.2013.1250

    Figure Lengend Snippet: Expression of VEGF was lower in (A) normal brain tissues than in (B) low-grade and (C) high-grade astrocytomas and higher in (C) high-grade astrocytomas than (B) low-grade astrocytomas. Expression of bFGF was lower in (D) normal brain tissues than in (E) low-grade and (F) high-grade astrocytomas and higher in (F) high-grade astrocytomas than (E) low-grade astrocytomas. (G) VEGF expression in astrocytomas decreased with increased BAI1 expression (Spearman’s rank correlation, r=−0.379, P<0.01). (H) bFGF expression in astrocytomas decreased with increased BAI1 expression (Spearman’s rank correlation, r=−0.277, P<0.01). BAI1, brain-specific angiogenesis inhibitor 1; VEGF, vascular endothelial growth factor; bFGF, basic fibroblast growth factor; LI, labeling index.

    Article Snippet: The sections were incubated with the following primary antibodies: rabbit anti-BAI1 affinity purified polyclonal antibody (AB9364, 1:1,000; Chemicon International, Temecula, CA, USA); CD105 (Endoglin) mouse monoclonal antibody (NCL-CD105, 1:100; Novocastra, Newcastle upon Tyne, UK); VEGF (C-1) mouse monoclonal antibody (sc-7269, 1:600; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); bFGF (147) rabbit polyclonal antibody (sc-79, 1:800; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).

    Techniques: Expressing, Labeling

    (A) BAI1 expression in astrocytomas was different in patients with various EIs. Astrocytoma specimens were divided into four groups according to their EI: group 1, EI ≤2; group 2, 2< EI ≤4; group 3, 4< EI ≤6; group 4, EI >6. * P<0.05 vs. groups 1 and 2. (B) PTBE in astrocytomas decreased with increased BAI1 expression (Spearman’s rank correlation, r=−0.380, P<0.01). BAI1, brain-specific angiogenesis inhibitor 1; EI, edema index; PTBE, peritumoral brain edema.

    Journal: Oncology Letters

    Article Title: Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas

    doi: 10.3892/ol.2013.1250

    Figure Lengend Snippet: (A) BAI1 expression in astrocytomas was different in patients with various EIs. Astrocytoma specimens were divided into four groups according to their EI: group 1, EI ≤2; group 2, 2< EI ≤4; group 3, 4< EI ≤6; group 4, EI >6. * P<0.05 vs. groups 1 and 2. (B) PTBE in astrocytomas decreased with increased BAI1 expression (Spearman’s rank correlation, r=−0.380, P<0.01). BAI1, brain-specific angiogenesis inhibitor 1; EI, edema index; PTBE, peritumoral brain edema.

    Article Snippet: The sections were incubated with the following primary antibodies: rabbit anti-BAI1 affinity purified polyclonal antibody (AB9364, 1:1,000; Chemicon International, Temecula, CA, USA); CD105 (Endoglin) mouse monoclonal antibody (NCL-CD105, 1:100; Novocastra, Newcastle upon Tyne, UK); VEGF (C-1) mouse monoclonal antibody (sc-7269, 1:600; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); bFGF (147) rabbit polyclonal antibody (sc-79, 1:800; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).

    Techniques: Expressing